Tango Other Liab from 2010 to 2024

TNGX Stock  USD 3.10  0.16  5.44%   
Tango Therapeutics Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to about 91.5 M in 2024. During the period from 2010 to 2024, Tango Therapeutics Other Liabilities regression line of annual values had r-squared of  0.63 and arithmetic mean of  47,663,384. View All Fundamentals
 
Other Liabilities  
First Reported
2010-12-31
Previous Quarter
131.9 M
Current Value
91.5 M
Quarterly Volatility
49.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tango Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tango Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 3.6 M or Selling General Administrative of 22.1 M, as well as many indicators such as Price To Sales Ratio of 19.37, Dividend Yield of 0.0 or PTB Ratio of 6.45. Tango financial statements analysis is a perfect complement when working with Tango Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tango Therapeutics Correlation against competitors.
For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.

Latest Tango Therapeutics' Other Liab Growth Pattern

Below is the plot of the Other Liab of Tango Therapeutics over the last few years. It is Tango Therapeutics' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tango Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Tango Other Liab Regression Statistics

Arithmetic Mean47,663,384
Geometric Mean28,326,436
Coefficient Of Variation104.33
Mean Deviation44,719,179
Median14,124,000
Standard Deviation49,725,810
Sample Variance2472.7T
Range117.8M
R-Value0.79
Mean Square Error981.2T
R-Squared0.63
Significance0.0004
Slope8,836,142
Total Sum of Squares34617.2T

Tango Other Liab History

202491.5 M
2023131.9 M
2021114.7 M
2020120.8 M

About Tango Therapeutics Financial Statements

Tango Therapeutics investors use historical fundamental indicators, such as Tango Therapeutics' Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tango Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities131.9 M91.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.